- Home
- SRPT vs LW Comparison
SRPT vs LW Comparison
Compare SRPT & LW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRPT
- LW
- Stock Information
- Founded
- SRPT 1980
- LW 1950
- Country
- SRPT United States
- LW United States
- Employees
- SRPT N/A
- LW N/A
- Industry
- SRPT Biotechnology: Pharmaceutical Preparations
- LW Packaged Foods
- Sector
- SRPT Health Care
- LW Consumer Staples
- Exchange
- SRPT Nasdaq
- LW Nasdaq
- Market Cap
- SRPT 12.2B
- LW 10.2B
- IPO Year
- SRPT 1997
- LW N/A
- Fundamental
- Price
- SRPT $120.39
- LW $78.60
- Analyst Decision
- SRPT Buy
- LW Buy
- Analyst Count
- SRPT 21
- LW 13
- Target Price
- SRPT $179.38
- LW $81.38
- AVG Volume (30 Days)
- SRPT 1.0M
- LW 2.0M
- Earning Date
- SRPT 11-06-2024
- LW 12-19-2024
- Dividend Yield
- SRPT N/A
- LW 1.76%
- EPS Growth
- SRPT N/A
- LW N/A
- EPS
- SRPT 1.22
- LW 4.26
- Revenue
- SRPT $1,640,348,000.00
- LW $6,456,400,000.00
- Revenue This Year
- SRPT $50.40
- LW $5.97
- Revenue Next Year
- SRPT $71.44
- LW $4.35
- P/E Ratio
- SRPT $103.94
- LW $19.24
- Revenue Growth
- SRPT 48.45
- LW 9.61
- 52 Week Low
- SRPT $89.92
- LW $52.99
- 52 Week High
- SRPT $173.25
- LW $111.88
- Technical
- Relative Strength Index (RSI)
- SRPT 50.01
- LW 58.53
- Support Level
- SRPT $122.12
- LW $70.35
- Resistance Level
- SRPT $128.73
- LW $83.98
- Average True Range (ATR)
- SRPT 3.87
- LW 2.81
- MACD
- SRPT -0.15
- LW 0.37
- Stochastic Oscillator
- SRPT 11.14
- LW 74.98
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.
About LW Lamb Weston Holdings Inc.
Lamb Weston is North America's largest and the world's second-largest producer of branded and private-label frozen potato products, both by volume and value. The company's portfolio is anchored by French fries, but it also sells sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. Roughly two-thirds of revenue comes from its home market of North America, with none of the other 100 countries the company sells into representing a significant share. McDonald's is Lamb Weston's single largest customer at 14% of fiscal 2024 sales, with no other company representing more than 10%. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.